Relationship between virulence and antimicrobial resistance in bacteria

Reviews and Research in Medical Microbiology

Volumn 20, Issue 4, 2009, Pages 84-90

  Soto, Sara M ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Antimicrobial resistance; Mobile genetic elements; Virulence

Indexed keywords

AZITHROMYCIN; CEFEPIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DIRITHROMYCIN; ERYTHROMYCIN; LINEZOLID; NEOMYCIN; PENICILLIN G; ROXITHROMYCIN; SPIRAMYCIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; BACTERIAL VIRULENCE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; SALMONELLA CHOLERAESUIS; SALMONELLA ENTERICA; STREPTOCOCCUS PNEUMONIAE; UROPATHOGENIC ESCHERICHIA COLI;

EID: 74249094205     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MRM.0b013e3283342903     Document Type: Review

References (65)

1. Smith H. The biochemical challenge of microbial pathogenicity. J Appl Bacteriol 1984; 57:395-404.
2. Finlay BB, Falkow S. Common themes in microbial pathogenicity. Microbiol Rev 1989; 53:210-230.
3. Hacker J, Blum-Oehler G, Mühldorfer I, Tschäpe H. Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution. Mol Microbiol 1997; 23:1089-1097.
4. Rychlik I,Gregorova D,HradeckaH. Distributionand functionof plasmids in Salmonella enterica. Vet Microbiol 2006; 112:1-10.
5. Bebora LC. Role of plasmids in the virulence of enteric bacteria. East Afr Med J 1997; 74:444-446.
6. Schwarz S, Chaslus-Dancla E. Use of antimicrobials in veterinary medicine and mechanisms of resistance. Vet Res 2001; 32:201-225. (Pubitemid 32595206)
7. Fàbrega A, Sánchez-Céspedes J, Soto S, Vila J. Quinolone resistance in the food chain. Int J Antimicrob Agents 2008; 31:307-315.
8. Carattoli A. Importance of integrons in the diffusion of resistance. Vet Res 2001; 32:243-259.
9. Bagel S, Heisig P, Wiedemann B. Fluoroquinolone resistance of Escherichia coli frequently is associated with decreased expression of type 1 fimbriae. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology; 1997. p. 42.
10. Blazquez R, Menasalvas A, Carpen I, Ramírez C, Guerrero C, Moreno S. Invasive disease caused by ciprofloxacin-resistant uropathogenic Escherichia coli. Eur J Clin Microbiol Infect Dis 1999; 18:503-505.
11. Sánchez UM, Bello TH, Domínguez YM, Mella MS, Zemelman ZR, González RG. Transference of extended-spectrum betalactamases from nosocomial strains of Klebsiella pneumoniae to other species of Enterobacteriaceae. Rev Med Chil 2006; 134:415-420.
12. Guerra B, Junker E, Miko A, Helmuth R, Mendoza MC. Characterization and localization of drug resistance determinants in multidrug-resistant, integron-carrying Salmonella enterica serotype Typhimurium strains. Microb Drug Resist 2004; 10:83-91.
13. Guerra B, Junker E,Miko A,HelmuthR,MendozaMC.Characterization and localization of drug resistance determinants inmultidrug- resistant, integron-carrying Salmonella enterica serotype Typhimurium strains. Microbial Drug Resist 2004; 2:83-91.
14. Chu C, Chiu CH, Wu WY, Chu CH, Liu TP, Ou JT. Large drug resistance virulence plasmids of clinical isolates of Salmonella enterica serovar Choleraesuis. Antimicrob Agents Chemother 2001; 45:2299-2303.
15. Chu C, Chiu CH. Evolution of the virulence plasmids of nontyphoid Salmonella and its association with antimicrobial resistance. Microbes Infect 2006; 8:1931-1936.
16. Carlson SA, Browning M, Ferris KE, Jones BD. Identification of diminished tissue culture invasiveness among multiple antibiotic resistant Salmonella typhimurium DT104. Microb Pathog 2000; 28:37-44.
17. Vila J, Simon K, Ruiz J, Horcajada JP, Velasco M, Barranco M, et al. Are quinolone-resistant uropathogenic Escherichia coli less virulent?. J Infect Dis 2002; 186:1039-1042.
18. Horcajada JP, Soto S, Gajewski A, Smithson A, Jiménez de Anta MT, Mensa J, et al. Quinolone-resistant uropathogenic Escherichia coli strain from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. J Clin Microbiol 2005; 43:2962-2964.
19. Martínez-Martínez L, Fernández F, Perea EJ. Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli. J Antimicrob Chemother 1999; 43:277-279.
20. Pérez-Trallero E, Urbieta M, Jimenez D, García-Arenzana JM, Cilla G. Ten-year survey of quinolone resistance in Escherichia coli causing urinary tract infections. Eur J Clin Microbiol Infect Dis 1993; 12:349-351.
21. Martínez-Martínez L, Suárez AI, Carranza R, Perea EJ. Resistencia a ciprofloxacino en bacilos gram negativos. Aspectos epidemioló gicos. Enfermedades Infecciosas y Microbiología Clínica 1993; 11:434-438.
22. Velasco M, Horcajada JP, Mensa J, Moreno-Martínez A, Vila J, Martínez JA, et al. Decreased invasive capacity of quinoloneresistant Escherichia coli in patients with urinary tract infections. Clin Infect Dis 2001; 33:1682-1686.
23. Blanco M, Blanco JE, Alonso MP, Blanco J. Virulence factors and O groups of Escherichia coli isolates from patients with acute pyelonephritis, cystitis and asymptomatic bacteriuria. Eur J Epidemiol 1996; 12:191-198.
24. Svanborg C, Godaly G. Bacterial virulence in urinary tract infection. Infect Dis Clin North Am 1997; 11:513-529.
25. Johnson JR. Virulence factors of Escherichia coli urinary tract infections. Clin Microbiol Rev 1991; 4:80-128.
26. Johnson JR. Expression of P fimbriae in urine. J Infect Dis 1988; 158:495-496.
27. Lo Bue AM, Geremia E, Castagna C, Chisari G, Nicoletti G. Sub-MIC ciprofloxacin effect on fimbrial production by uropathogenic Escherichia coli strains. J Chemother 1999; 11:357-362.
28. Baskin H, Dogan Y, Bahar IH, Yulug N. Effect of subminimal inhibitory concentrations of three fluoquinolones on adherence of uropathogenic strains of Escherichia coli. Int J Antimicrobial Agents 2002; 19:79-82. (Pubitemid 34119076)
29. Bagel S, Hüllen V, Wiedemann B, Heisig P. Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli. Antimicrob Agents Chemother 1999; 43:868-875.
30. Dove SL, Dorman CJ. The site-specific recombination system regulating expression of the type 1 fimbrial subunit gene of Escherichia coli is sensitive to changes in DNA supercoiling. Mol Microbiol 1994; 14:975-988.
31. Kelly A, Conway C, O Croinin T, Smith SG, Dorman CJ. DNA supercoiling and the Lrp protein determine the directionally of fim switch DNA inversion in Escherichia coli K-12. J Bacteriol 2006; 188:5356-5363.
32. Tessier MC, Graveline R, Crost C, Desabrais JA, Martin C, Drolet M, Harel J. Effects of DNA supercoiling and topoisomerases on the expression of genes coding for F1651, a P-like fimbriae. FEMS Microbiol Lett 2007; 277:28-36.
33. Hariharan H, Heaney S, Bryenton J, Daley J. Observations on production of hemolysin, heat-labile enterotoxin and antimicrobial drug resistance among enterotoxigenic Escherichia coli from pigs. Microbiol Infect Dis 1992; 15:229-234.
34. Vranes J. Effect of subinhibitory concentrations of ceftazidime, ciprofloxacin, and azithromycin on the hemagglutination and adherence of uropathogenic Escherichia coli. Chemotherapy 1996; 42:177-185. (Pubitemid 26095172)
35. Baskin H, Dogan Y, Hakki BI, Yulug N. Effect of subminimal inhibitory concentrations of gentamicin, penicillin, trimethoprim- sulfamethoxazole on uropathogenic Escherichia coli strains. J Chemother 2002; 14:161-165. (Pubitemid 34454630)
36. Soto SM, Jimenez de Anta MT, Vila J. Quinolones induce partial or total loss of pathogenicity islands in uropathogenic Escherichia coli by SOS-dependent or -independent pathways, respectively. Antimicrob Agents Chemother 2006; 50:649-653.
37. Vranes J, Schonwald S, Zagar Z. Relation between P-fimbriae and resistance to amoxicillin, carbenicillin and tetracycline in uropathogenic strains of Escherichia coli. Lijec Vjesn 1994; 116:178-181.
38. Balagué C, Fernández L, Pérez J, Grau R. Effect of ciprofloxacin on adhesive properties of non-P mannose-resistant uropathogenic Escherichia coli isolates. J Antimicrob Chemother 2003; 51:401-404.
39. Kachroo BB. Association between antibiotic resistance and the expression of Dr adhesin among uropathogenic Escherichia coli. Chemotherapy 2001; 47:97-103.
40. GordonDM. The influence of ecological factors on the distribution and genetic structure of Escherichia coli. In: Neidherdt F, Umberger HE, editors. Escherichia coli and Salmonella typhimurium: cellular and molecular biology. Washington, DC, USA: ASM.
41. Johnson JR, Delavari P, Kuskowski M, Stell AL. Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli. J Infect Dis 2001; 183:78-88.
42. Quinn JP. Clinical problems posed by multiresistant nonfermenting gram-negative pathogens. Clin Infect Dis 1998; 27:S117-S124.
43. Govan JR, Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 1996; 60:539-574.
44. Köhler T, Van Delden C, Curty LK, Hamzehpour MM, Pechere JC. Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa. J Bacteriol 1997; 183:5213-5222.
45. Linares JF, López JA, Camafeita E, Albar JP, Rojo F, Martínez JL. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa. J Bacteriol 2005; 187: 1384-1391.
46. Li XZ, Livermore DM, Nikaido H. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob Agents Chemother 1994; 38:1732-1741. (Pubitemid 24250718)
47. Poole K, Gotoh N, Tsujimoto H, Zhao Q, Wada A, Yamasaki T, et al. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Mol Microbiol 1996; 21:713-724.
48. Köhler T, Michea-Hamzehpour M, Henze U, Gotoh N, Curty LK, Pechere JC. Chracterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol Microbiol 1997; 23:345-354.
49. Mine T, Morita Y, Karaota A, Mizushima T, Tsuchiya T. Expression in Escherichia coli of a new multidrug efflux pump, MexXY, from Pseudomonas aeruginosa. Antimicrob Agents Chemother 1999; 43:415-417.
50. Evans K, Passador L, Srikumar R, Tsang E, Nezezon J, Poole K. Influence of MexAB-OprM multidrug efflux system on quorum sensing in Pseudomonas aeruginosa. J Bacteriol 1998; 180:5443-5447.
51. Nicas TL, Iglewski H. Contribution of exoenzyme S to the virulence of Pseudomonas aeruginosa. Antibiot Chemother 1985; 36:40-48.
52. Pesci EC, Pearson JP, Seed PC, Iglewski BH. Regulation of las and rhl quorum sensing in Pseudomonas aeruginosa. J Bacteriol 1997; 179:3127-3132.
53. Hueck CJ. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev 1998; 62:379-433.
54. Okazaki M, Onogawa T, Araki K, Egami T, Furuya N, Endo N, Uchimura H. Isolation frequency and biological characteristics of the multiple-antibiotic resistant Pseudomonas aeruginosa isolated from clinical specimens. Kansenshogaku Zasshi 1997; 71:1181-1186l.
55. Hsu D, Okamoto M, Murthy R, Wong-Beringer A. Fluoroquinolone resistant Pseudomonas aeruginosa: risk for acquisition and impact on outcome. J Antimicrob Chemother 2005; 55:535-541.
56. Wong-Beringer A, Wiener-Kronish J, Lynch S, Flanagan J. Comparison of type III secretion system virulence among fluoroquinolone- susceptible and resistant clinical isolates of Pseudomonas aeruginosa. Clin Microbiol Infect 2008; 14:330-336.
57. Jeannot K, Elsen S, Köhler T, Attree I, van Delden C, Plésiat P. Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump. Antimicrob Agents Chemother 2008; 52:2455-2462.
58. Schmitz FJ, Mackenzie CR, Geisel R, Wagner S, Idel H, Verhoef J, et al. Enterotoxin and toxic shock syndrome toxin-1 production of methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains. Eur J Epid 1997; 13:699-708. (Pubitemid 27375076)
59. Melzer M, Eykyn SJ, Gransden WR, Chinn S. Is methicillinresistant Staphylococcus aureus more virulent than methicillin- susceptible Staphylococcus aureus? A comparative cohort study of british patients with nosocomial infection and bacteraemia. Clin Infect Dis 2003; 37:1453-1460.
60. Stevens DL, Ma Y, Salmi DB, McIndoo E, Wallace RJ, Bryant AE. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis 2007; 195:202-211.
61. Kuroda H, Kuroda M, Cui L, Hitamtsu K. Subinhibitory concentrations of beta-lactam induce haemolytic activity in Staphylococcus aureus through the SaeRS two-component system. FEMS Microbiol Lett 2007; 268:98-105.
62. Fuursted K, Knudsen JD, Petersen MB, Poulsen RL, Rehm D. Comparative study of bactericidal activities, postantibiotic effects, and effects on bacterial virulence of penicillin G and six macrolides against Streptococcus pneumoniae. Antimicrob Agents Chemother 1997; 41:781-784.
63. Guillemot D, Varon E, Bernède C, Weber P, Henriet L, Simon S, et al. Reduction of antibiotic use in the community reduces the rate of colonization with penicillin G-nonsusceptible Streptococcus pneumoniae. Clin Infect Dis 2005; 41:930-938.
64. Johnson CN, Briles DE, Benjamin WH Jr, Hollingshead SK, Waites KB. Relative fitness of fluoroquinolone-resistant Streptococcus pneumoniae. Emerg Infect Dis 2005; 11:814-820.
65. Rieux V, Carbon C, Azoulay-Dupuis E. Complex relationship between acquisition of b-lactamresistance and loss of virulence in Streptococcus pneumoniae. J Infect Dis 2001; 184:66-72.